Shire PLC (NASDAQ:SHPG)‘s stock had its “outperform” rating reissued by analysts at Royal Bank of Canada in a research report issued on Tuesday. They currently have a $221.00 target price on the biopharmaceutical company’s stock. Royal Bank of Canada’s price objective would suggest a potential upside of 28.53% from the stock’s previous close. SHPG has […]
